Guardant Health (GH) Income from Continuing Operations (2017 - 2026)
Guardant Health (GH) posted Income from Continuing Operations of 120142000.0 for Q2 2026, down 7.2% sequentially from 112075000.0 in Q1 2026, and down 20.26% YoY from 150673717.71 in Q2 2025.
Guardant Health (GH) Income from Continuing Operations (2017 - 2026) Analysis & Trends
Guardant Health has reported Income from Continuing Operations for 10 years, with the latest figure at 120142000.0 in Q2 2026.
- Quarterly Income from Continuing Operations fell 20.26% year-over-year to 120142000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 453436000.0 (down 9.57% YoY) and the FY2025 annual result came in at 416277000.0, up 4.61% from the prior year.
- Income from Continuing Operations fell to 120142000.0 in Q2 2026 per GH's latest filing, from 112075000.0 in the prior quarter.
- Over five years, Income from Continuing Operations peaked at 72771000.0 in Q2 2023 and troughed at 229432000.0 in Q2 2022.
- A 5-year average of 123272444.44 and a median of 113530000.0 in 2024 frame the typical range for Income from Continuing Operations.
- The sharpest annual moves came in 2022 and 2023: Income from Continuing Operations tumbled 135.13% in 2022, then jumped 68.28% in 2023.
- Over 5 years, Income from Continuing Operations stood at 139934000.0 in 2022, then slumped by 33.67% to 187043000.0 in 2023, then jumped by 40.65% to 111006000.0 in 2024, then fell by 15.75% to 128494000.0 in 2025, then gained by 6.5% to 120142000.0 in 2026.
- According to Business Quant data, Income from Continuing Operations over the past three periods registered 120142000.0, 112075000.0, and 128494000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 1.76 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 870.00 Mn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | -66.93 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 339.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 241.00 Mn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 338.41 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 207.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 232.90 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 299.10 Mn |
| 10 | Guardant Health | 22.38 Bn | 21.33 Bn | 219.03 Mn | -120.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -120.14 Mn |
| Mar 31, 2026 | -112.08 Mn |
| Dec 31, 2025 | -128.49 Mn |
| Sep 30, 2025 | -92.73 Mn |
| Jun 30, 2025 | -99.90 Mn |
| Mar 31, 2025 | -95.16 Mn |
| Dec 31, 2024 | -111.01 Mn |
| Sep 30, 2024 | -107.75 Mn |
| Jun 30, 2024 | -102.63 Mn |
| Mar 31, 2024 | -114.99 Mn |
| Dec 31, 2023 | -187.04 Mn |
| Sep 30, 2023 | -86.10 Mn |
| Jun 30, 2023 | -72.77 Mn |
| Mar 31, 2023 | -133.53 Mn |
| Dec 31, 2022 | -139.93 Mn |
| Sep 30, 2022 | -161.99 Mn |
| Jun 30, 2022 | -229.43 Mn |
| Mar 31, 2022 | -123.23 Mn |
| Dec 31, 2021 | -72.31 Mn |
| Sep 30, 2021 | -107.53 Mn |